References:
1. Brooks JA. The Hospital-Acquired Condition Reduction Program. AJN, American Journal of Nursing 2017;117(10):63-66.
2. Korin J. Cost implications of malpractice and adverse events. Hosp Formul 1993;28 Suppl 1:59-61.
3. Baker GR.Harvard medical practice study.
4. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 1991;324(6):370-376.
5. Duchman KR, Pugely AJ, Martin CT, Bedard NA, Gao Y, Callaghan JJ. Medicare’s Hospital-Acquired Conditions Policy: A Problem of Nonpayment After Total Joint Arthroplasty. The Journal of Arthroplasty 2016;31(9):31-36.
6. Cromarty J, Parikh S, Lim WK, Acharya S, Jackson TJ. Effects of hospital-acquired conditions on length of stay for patients with diabetes. INTERN MED J 2014;44(11):1109-1116.
7. Jackson TJ, Michel JL, Roberts RF, Jorm CM, Wakefield JG. A classification of hospital-acquired diagnoses for use with routine hospital data. Med J Aust 2009;191(10):544-548.
8. Lee GM, Kleinman K, Soumerai SB, et al. Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med 2012;367(15):1428-1437.
9. Fuller RL, Goldfield NI, Averill RF, Hughes JS. Is the CMS Hospital-Acquired Condition Reduction Program a Valid Measure of Hospital Performance? AM J MED QUAL 2016;32(3):254-260.
10. Bae S. CMS Nonpayment Policy, Quality Improvement, and Hospital-Acquired Conditions. J NURS CARE QUAL 2017;32(1):55-61.
11. Wendelboe AM, McCumber M, Hylek EM, Buller H, Weitz JI, Raskob G. Global public awareness of venous thromboembolism. J THROMB HAEMOST 2015;13(8):1365-1371.
12. Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden. SEMIN THROMB HEMOST 2014;40(7):724-735.
13. Zhang Z, Lei J, Shao X, et al. Trends in Hospitalization and In-Hospital Mortality From VTE, 2007 to 2016, in China. CHEST 2019;155(2):342-353.
14. Young PY, Khadaroo RG. Surgical site infections. Surg Clin North Am 2014;94(6):1245-1264.
15. Branchford B. Clinical and financial impact of HACs: a commentary on clinical and financial costs of hospital-acquired conditions. Translational pediatrics 2015;4(4
):331-333.
16. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J AM COLL CARDIOL 2002;40(3):418-423.
17. Demarre L, Van Lancker A, Van Hecke A, et al. The cost of prevention and treatment of pressure ulcers: A systematic review. INT J NURS STUD 2015;52(11):1754-1774.
18. Services CFMA. Hospital-Acquired Condition Reduction Program (HACRP).
19. Roberson B, Reid K. HAC REDUCTION PROGRAM PENALTIES: AN UNDUE BURDEN ON ESSENTIAL HOSPITALS. Washington, DC: Essential Hospitals Institute.
Table 1. The amount, percentage, demographic, financial and length information of all inpatients for Hospital-Acquired Conditions in three years.